165 related articles for article (PubMed ID: 7689130)
1. Role of C-kit receptor in the diagnosis of leukemia: a relationship between expression of C-kit receptor and that of CD33 in leukemic blasts.
Muroi K; Amemiya Y; Miura Y; Nakamura M; Suda T
Leuk Res; 1993 Aug; 17(8):725-6. PubMed ID: 7689130
[No Abstract] [Full Text] [Related]
2. Enhanced myeloid specificity of CD117 compared with CD13 and CD33.
Nomdedéu JF; Mateu R; Altès A; Llorente A; Rio C; Estivill C; López O; Ubeda J; Rubiol E
Leuk Res; 1999 Apr; 23(4):341-7. PubMed ID: 10229319
[TBL] [Abstract][Full Text] [Related]
3. The receptor tyrosine kinase p185HER2 is expressed on a subset of B-lymphoid blasts from patients with acute lymphoblastic leukemia and chronic myelogenous leukemia.
Bühring HJ; Sures I; Jallal B; Weiss FU; Busch FW; Ludwig WD; Handgretinger R; Waller HD; Ullrich A
Blood; 1995 Sep; 86(5):1916-23. PubMed ID: 7544646
[TBL] [Abstract][Full Text] [Related]
4. T lymphoid/myeloid bilineal crisis in chronic myelogenous leukemia.
Akashi K; Mizuno S; Harada M; Kimura N; Kinjyo M; Shibuya T; Shimoda K; Takeshita M; Okamura S; Matsumoto I
Exp Hematol; 1993 Jun; 21(6):743-8. PubMed ID: 7684698
[TBL] [Abstract][Full Text] [Related]
5. CD7 expression on CD34+ cells from chronic myeloid leukaemia in chronic phase.
Martín-Henao GA; Quiroga R; Sureda A; García J
Am J Hematol; 1999 Jul; 61(3):178-86. PubMed ID: 10398310
[TBL] [Abstract][Full Text] [Related]
6. Expression of c-kit receptor (CD117) and CD34 in leukemic cells.
Muroi K; Nakamura M; Amemiya Y; Suda T; Miura Y
Leuk Lymphoma; 1995 Jan; 16(3-4):297-305. PubMed ID: 7536510
[TBL] [Abstract][Full Text] [Related]
7. Supersaturating infusional humanized anti-CD33 monoclonal antibody HuM195 in myelogenous leukemia.
Caron PC; Dumont L; Scheinberg DA
Clin Cancer Res; 1998 Jun; 4(6):1421-8. PubMed ID: 9626458
[TBL] [Abstract][Full Text] [Related]
8. CD33, CD4-double positive blastic transformation in a patient with chronic myelogenous leukemia.
Hirayama Y; Kohgo Y; Kanisawa Y; Fujii S; Ikeda K; Matsunaga T; Ito Y; Sakamaki S; Niitsu Y
Int J Hematol; 1993 Jun; 57(3):265-8. PubMed ID: 8364189
[TBL] [Abstract][Full Text] [Related]
9. Leukemia-associated phenotypes: their characteristics and incidence in acute leukemia.
Babusíková O; Glasová M; Koníková E; Kusenda J
Neoplasma; 1996; 43(6):367-72. PubMed ID: 8996560
[TBL] [Abstract][Full Text] [Related]
10. Kit ligand/mast cell growth factor-independent differentiation of mast cells in myelodysplasia and chronic myeloid leukemic blast crisis.
Valent P; Spanblöchl E; Bankl HC; Sperr WR; Marosi C; Pirc-Danoewinata H; Virgolini I; Eichler HG; Agis H; Sillaber C
Blood; 1994 Dec; 84(12):4322-32. PubMed ID: 7527672
[TBL] [Abstract][Full Text] [Related]
11. [CD33-positive acute lymphoblastic leukemia with breast tumor and cavernous sinus tumor].
Ishida T; Yoshimoto M; Ono A; Saitoh N; Nakano T; Higashide T; Sugiyama T; Hinota Y; Imai K; Yachi A
Rinsho Ketsueki; 1989 Dec; 30(12):2194-8. PubMed ID: 2621803
[TBL] [Abstract][Full Text] [Related]
12. Growth of human myeloid leukemias in the human marrow environment of SCID-hu mice.
Namikawa R; Ueda R; Kyoizumi S
Blood; 1993 Oct; 82(8):2526-36. PubMed ID: 8104540
[TBL] [Abstract][Full Text] [Related]
13. Differences between blastic chronic myeloid leukemia and Ph-positive acute leukemia.
Berger R
Leuk Lymphoma; 1993; 11 Suppl 1():235-7. PubMed ID: 8251902
[TBL] [Abstract][Full Text] [Related]
14. Identification of the CD33-related Siglec receptor, Siglec-5 (CD170), as a useful marker in both normal myelopoiesis and acute myeloid leukaemias.
Virgo P; Denning-Kendall PA; Erickson-Miller CL; Singha S; Evely R; Hows JM; Freeman SD
Br J Haematol; 2003 Nov; 123(3):420-30. PubMed ID: 14617000
[TBL] [Abstract][Full Text] [Related]
15. Immunocytochemical staining of normal and leukemic myeloid cells with the antibody EBM11 (CD68).
Shome DK; Raju GM; Gupta NK
Acta Haematol; 1998; 100(4):216-8. PubMed ID: 9973648
[No Abstract] [Full Text] [Related]
16. Cytogenetically aberrant cells are present in the CD34+CD33-38-19- marrow compartment in children with acute lymphoblastic leukemia.
Quijano CA; Moore D; Arthur D; Feusner J; Winter SS; Pallavicini MG
Leukemia; 1997 Sep; 11(9):1508-15. PubMed ID: 9305606
[TBL] [Abstract][Full Text] [Related]
17. Bilineage T-lymphoblastic/myeloid extramedullary blast crisis in chronic myelogenous leukemia.
Nair IM; Feroze M; Aravindan KP
Indian J Pathol Microbiol; 2016; 59(1):107-9. PubMed ID: 26960653
[TBL] [Abstract][Full Text] [Related]
18. Flow cytometric detection of residual disease in acute leukemia by assaying blasts co-expressing myeloid and lymphatic antigens.
Syrjälä M; Anttila VJ; Ruutu T; Jansson SE
Leukemia; 1994 Sep; 8(9):1564-70. PubMed ID: 7522295
[TBL] [Abstract][Full Text] [Related]
19. [Immunophenotyping of acute leukemias: diagnostic and pronostic utility in Abidjan, Côte d'Ivoire].
Inwoley KA; Sawadogo D; Mizero L; Salou M; Karim N; Sangaré A
Bull Soc Pathol Exot; 2004; 97(5):319-22. PubMed ID: 15787262
[TBL] [Abstract][Full Text] [Related]
20. Expression of complement regulatory proteins CR1, DAF, MCP and CD59 in haematological malignancies.
Guc D; Canpinar H; Kucukaksu C; Kansu E
Eur J Haematol; 2000 Jan; 64(1):3-9. PubMed ID: 10680700
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]